Vi-DT typhoid conjugate vaccine, developed jointly by the International Vaccine Institute (IVI) and SK bioscience, has met the primary endpoints in a phase III study in Nepal This study is ...
Read moreTopic: Vaccine Development
Biological E. unveils typhoid conjugate vaccine, commissions ₹300-cr plant near Hyderabad
Biological E. Ltd on Monday commissioned its manufacturing plant at the Genome Valley Special Economic Zone near here and unveiled its new Typhoid Conjugate Vaccine (TCV) Recently, BE received authorisation ...
Read moreEnteric Fever Vaccine Candidate to Launch Phase 1 Study
A London based biotechnology company has received Clinical Trial Authorization acceptance from the UK Medicines and Healthcare products Regulatory Agency to conduct a first-in-human Phase I trial for Entervax™, a ...
Read moreProkarium Secures £4.6M from Wellcome to Fund the Clinical Development of its Lead Vaccine Programme
Prokarium announced it has received an investment of £4.59 million from Wellcome to fund two clinical trials of its lead programme, Entervax™, a bivalent vaccine against enteric fever Entervax™ is ...
Read moreTyphoid Fever Vaccines Market 2025: Comprehensive Study Explores Huge Revenue Scope in Future | Leading Key Players: Prokarium, GlaxoSmithKline Plc, Shanghai Institute of Biological Products Co Ltd
The Global Typhoid Fever Vaccines Market report aims to provide a complete 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with ...
Read moreTyphoid Vaccine Market Recent and Future Demand | Sanofi, Merck, GlaxoSmithKline
The Worldwide Typhoid Vaccine Industry, 2019-2029 Market Research Report is an efficient and detailed study on the present situation of the industry by focusing on the global market. Typhoid Vaccine ...
Read moreAdvanced BioNutrition Announces Collaboration with the Center for Vaccine Development and Global Health (CVD) of the University of Maryland School of Medicine to Develop a Heat-resistant Formulation of CVD’s Live Oral Salmonella Paratyphi A Vaccine
Advanced BioNutrition Corp. (ABN), a leading provider of advanced stabilization and delivery solutions across the health and nutrition, agriculture, and biopharma industries, announced today that it is collaborating with Myron ...
Read moreDoes a typhoid vaccine protect against multiple threats?
A recent study investigated the protective effects of a typhoid vaccine against microbes that are not the target of prevention. Analysis of immune system cells called monocytes revealed their activation ...
Read moreIVI gets $15.7 million to conduct P3 trials for Vi-DT typhoid conjugate vaccine
The International Vaccine Institute (IVI) said it has received a $15.7 million grant from the Bill & Melinda Gates Foundation to develop a typhoid conjugate vaccine for public sector markets. ...
Read moreSafety of typhoid conjugate vaccine
WHO received newly available data on the Vi-tetanus toxoid conjugate vaccine Typbar TCVTM (produced by Bharat Biotech International Limited), currently the only licensed TCV available internationally and prequalified by WHO. ...
Read more
